Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05407727 · ClinicalTrials.gov registry record
A Prospective, Remote Observational Study in Pediatric Participants With Early-Onset SCN2A-Developmental and Epileptic Encephalopathy
A clinical trial, sponsored by Praxis Precision Medicines.
- Completed
- Registry status
- 5
- Enrollment target
NCT05407727 is a clinical trial that has completed, run by Praxis Precision Medicines. The registered enrollment target is 5 participants.
The verdict
NCT05407727 has completed, sponsored by Praxis Precision Medicines.
- COMPLETED
- Registry status
- 5 participants
- Enrollment target
Study Summary
This prospective observational study is designed to assess the individualized baseline disease burden in pediatric participants aged 1 year to 16 years, with early-onset SCN2A-DEE by characterizing and quantifying changes in clinical features over a period of up to 12 months.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2022-04-15 |
| Est. Completion | 2023-03-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05407727
The ClinicalTrials.gov registry entry for NCT05407727 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Praxis Precision Medicines, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT05407727 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05407727 about?
NCT05407727 is a clinical study titled "A Prospective, Remote Observational Study in Pediatric Participants With Early-Onset SCN2A-Developmental and Epileptic Encephalopathy". This prospective observational study is designed to assess the individualized baseline disease burden in pediatric participants aged 1 year to 16 years, with early-onset SCN2A-DEE by characterizing and quantifying changes in clinical features over a period of up to 12 months.
What is the current status of trial NCT05407727?
This trial is currently completed. The enrollment target is 5 participants. The study started on 2022-04-15. Estimated completion is 2023-03-31.
Who is sponsoring clinical trial NCT05407727?
This trial is sponsored by Praxis Precision Medicines, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.